Exploring the future of cancer research at the 2025 Bionow Oncology Conference

-

Hosted at the newly-reopened Apiary Conference Centre at Alderley Park, the Bionow Oncology Conference on 27th November welcomed around 100 delegates, speakers and exhibitors with a deep dive into the latest advancements and challenges in cancer research, fostering collaboration and innovation across the healthcare sector.

The agenda covered a wide range of topics, including research and development, clinical and supply, and manufacturing, alongside patient perspective insights, a state of the nation panel and a poster presentation session for oncology researchers to showcase their work.

Read the full event summary here

 
The 2025 Oncology Conference was sponsored by Appleyard Lees and Bruntwood SciTech.

 

Agenda highlights:

Keynote Speakers

  • David Jennis, Director of Sterile Manufacturing Integration and Strategic Network Collaboration, GSK Barnard Castle

  • Laura Rosenberg, Director of Target Validation within Discovery Sciences, AstraZeneca

 

State of the Nation

Chair: Kate Hickinson, Partner, Appleyard Lees

Speakers

  • Allan Jordan, Vice President of Oncology Drug Discovery, Synature Discovery

  • Matthew Taylor, Director, York Health Economics Consortium

  • Peter Leather, IP & Innovation Manager, Liverpool John Moores University

  • Jenny Thirlway, Executive Director, Iksuda Therapeutics

  • Nathalie Dhomen, Translation Executive, Cancer Research Horizons

  • Suzanne Robb, Senior Market Strategy Manager, Centre for Process Innovation (CPI)

 

Research & Development

Chair: Mark Julian, Associate Commercial Director, Bruntwood SciTech

Speakers

  • Sam Butterworth, Professor of Medicinal Chemistry, University of Manchester

  • Cole Sims, Business Development Lead, LightOx

  • Gray Kueberuwa, CEO, Immunokey

  • Anita Liu, Senior Scientist, Medicines Discovery Catapult

 

Poster Spotlight

 

Patient Perspective

Chris Curtis, CEO, The Swallows Head and Neck Cancer Support Group

 

Clinical & Supply

Speakers

  • Stephanie-Jayne Jones, Chief Medical Officer, Pharmora

  • Michael Morton, Director and Co-Founder, ApconiX

  • Mireia Sueca‑Comes, Client Account Manager, HistologiX

 

Manufacturing

Speakers

  • Mike Tobyn, Senior Scientific Director | Drug Product Development, BMS

  • Matt Ling, Director, Scientific Product Development, Catalent

  • Hélène Trottin, Associate Director Biologics Development, Pharmaron

  • Lewis White, Mechanical Engineering Team Leader, Scitech-EKIUM